Trials / Sponsors / Nanolattix Biotechnology Co., Ltd.
Nanolattix Biotechnology Co., Ltd.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors Advanced Solid Tumor (Phase 1) | Phase 1 | 2027-12-01 |
| Recruiting | Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors Solid Tumors | EARLY_Phase 1 | 2026-01-29 |